{
  "abstract": "In recent decades therapeutic antibodies have become recognised as an effective form of systemic therapy in the management of many paediatric conditions from Crohn’s disease to asthma and cancer. 1–3",
  "authors": [
    {
      "affiliations": [
        "Cancer and Genomic Sciences, University of Birmingham, Birmingham, England, UK",
        "Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK"
      ],
      "name": "Katherine Crombie"
    },
    {
      "affiliations": [
        "Cancer and Genomic Sciences, University of Birmingham, Birmingham, England, UK",
        "Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK"
      ],
      "name": "Sandeep Potluri"
    },
    {
      "affiliations": [
        "Cancer and Genomic Sciences, University of Birmingham, Birmingham, England, UK",
        "Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK"
      ],
      "name": "John R Apps"
    }
  ],
  "title": "What are bispecific antibodies?",
  "uid": "dce042a9-db9d-5a61-89ef-eb4aee1586b6"
}